• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[环磷酰胺致绝经前系统性红斑狼疮女性闭经]

[Cyclophosphamide induced amenorrhoea in pre-menopausal women with systemic lupus erythematosus].

作者信息

Cunha Inês, Saavedra Maria João, Pereira da Silva José António, Malcata Armando

机构信息

Serviço de Reumatologia dos Hospitais da Universidade de Coimbra, Coimbra, Portugal.

出版信息

Acta Reumatol Port. 2008 Jan-Mar;33(1):69-76.

PMID:18344924
Abstract

OBJECTIVES

To determine the frequency of ovarian failure in pre-menopausal women after cyclophosphamide (cyc) treatment for systemic lupus erythematosus (SLE); identify risk factors for this complication; estimate the occurrence and viability of pregnancy during and after treatment.

METHODS

Review of the data of women treated with intravenous cyc in the department of Rheumatology of Hospitais da Universidade de Coimbra, updated by interview. Information on demographic features; gynaecologic and obstetrical history; characteristics of the disease; duration and side effects of treatment were obtained. Ovarian failure was defined as a lack of menses for, at least, four months and the diagnosis was confirmed by hormonal measurements.

RESULTS

Nineteen pre-menopausal women were treated with intravenous cyc in our department. The mean age at the time of cyc initiation was 28.4 years. Lupus nephritis was the most common indication for cyc treatment (89.5%). The mean number of pulses was 9.3 over a period of 16.8 months. The mean cumulative dosage was 6.973 mg. Three patients developed ovarian failure. Those women were older than the others (P=0.0016). One patient became pregnant while on treatment. Two women delivered healthy children after cyc withdrawal.

CONCLUSION

Ovarian failure developed in 15.8% of our patients. As described in the literature, the age at cyc initiation appears to be a determinant risk factor. Pregnancy may occur during cyc therapy, and thus, an effective contraception is mandatory. After cyc withdrawal, pregnancy is possible with a favourable outcome.

摘要

目的

确定环磷酰胺(cyc)治疗系统性红斑狼疮(SLE)后绝经前女性卵巢功能衰竭的发生率;识别该并发症的危险因素;评估治疗期间及治疗后妊娠的发生情况和可行性。

方法

回顾科英布拉大学医院风湿病科接受静脉注射cyc治疗的女性患者数据,并通过访谈进行更新。获取了有关人口统计学特征、妇科和产科病史、疾病特征、治疗持续时间和副作用的信息。卵巢功能衰竭定义为至少四个月无月经,通过激素测量确诊。

结果

我们科室有19名绝经前女性接受了静脉注射cyc治疗。开始使用cyc时的平均年龄为28.4岁。狼疮性肾炎是cyc治疗最常见的适应症(89.5%)。在16.8个月的时间里,平均脉冲次数为9.3次。平均累积剂量为6973毫克。3名患者出现卵巢功能衰竭。这些女性比其他女性年龄更大(P = 0.0016)。1名患者在治疗期间怀孕。2名女性在停用cyc后产下健康婴儿。

结论

我们的患者中有15.8%发生了卵巢功能衰竭。如文献所述,开始使用cyc时的年龄似乎是一个决定性的危险因素。cyc治疗期间可能会怀孕,因此必须采取有效的避孕措施。停用cyc后,怀孕是可能的,且预后良好。

相似文献

1
[Cyclophosphamide induced amenorrhoea in pre-menopausal women with systemic lupus erythematosus].[环磷酰胺致绝经前系统性红斑狼疮女性闭经]
Acta Reumatol Port. 2008 Jan-Mar;33(1):69-76.
2
Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.静脉注射环磷酰胺后卵巢功能衰竭和生育能力的风险。对84例患者的研究。
J Rheumatol. 2002 Dec;29(12):2571-6.
3
Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.接受环磷酰胺治疗的系统性红斑狼疮患者卵巢功能衰竭的危险因素。
Arthritis Rheum. 1998 May;41(5):831-7. doi: 10.1002/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1.
4
Ovarian failure and flares of systemic lupus erythematosus.卵巢功能衰竭与系统性红斑狼疮病情发作
Arthritis Rheum. 1999 Jun;42(6):1274-80. doi: 10.1002/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B.
5
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.环磷酰胺治疗弥漫性增殖性狼疮性肾炎的长期预后
Am J Med. 2006 Apr;119(4):355.e25-33. doi: 10.1016/j.amjmed.2005.08.045.
6
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus.绝经前系统性红斑狼疮女性患者静脉注射脉冲式环磷酰胺后持续性闭经的预测因素
J Rheumatol. 2002 Oct;29(10):2129-35.
7
Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.在患有严重狼疮的女性中,使用促性腺激素释放激素类似物预防环磷酰胺治疗期间的卵巢早衰。
Arthritis Rheum. 2005 Sep;52(9):2761-7. doi: 10.1002/art.21263.
8
[Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy].[接受环磷酰胺治疗的系统性红斑狼疮患者卵巢功能衰竭的危险因素]
Zhonghua Yi Xue Za Zhi. 2005 Apr 13;85(14):960-2.
9
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.环磷酰胺成功治疗弥漫性增殖性狼疮性肾炎后肾复发的预测因素及结局
Arthritis Rheum. 2004 Aug;50(8):2559-68. doi: 10.1002/art.20364.
10
Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.环磷酰胺治疗 6 个月后序贯霉酚酸酯治疗可保留严重系统性红斑狼疮女性的卵巢功能。
Clin Exp Rheumatol. 2010 Jan-Feb;28(1):83-6.

引用本文的文献

1
Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis.系统性红斑狼疮患者骨密度降低的患病率及危险因素:一项荟萃分析
Biomed Res Int. 2019 Feb 20;2019:3731648. doi: 10.1155/2019/3731648. eCollection 2019.
2
Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis.静脉注射环磷酰胺联合激素治疗儿童起病的严重狼疮性肾炎。
Int Urol Nephrol. 2013 Oct;45(5):1301-8. doi: 10.1007/s11255-012-0331-9. Epub 2012 Dec 7.